SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-064944
Filing Date
2022-03-04
Accepted
2022-03-04 06:06:04
Documents
13
Period of Report
2022-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d252642d8k.htm   iXBRL 8-K 25901
2 EX-10.1 d252642dex101.htm EX-10.1 220719
  Complete submission text file 0001193125-22-064944.txt   422938

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amti-20220303.xsd EX-101.SCH 2862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amti-20220303_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amti-20220303_pre.xml EX-101.PRE 10816
7 EXTRACTED XBRL INSTANCE DOCUMENT d252642d8k_htm.xml XML 3250
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-392-0420
Applied Molecular Transport Inc. (Filer) CIK: 0001801777 (see all company filings)

IRS No.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39306 | Film No.: 22711994
SIC: 2834 Pharmaceutical Preparations